| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |